Skip to main content

Bovine Colostrum

Common Name(s): BCC (bovine colostrum concentrate), Bovine colostrum, Cow milk colostrum, Early milk, Hyperimmune milk, Immune milk, Lactobin, Lactoferrin, LC2N

Medically reviewed by Drugs.com. Last updated on Dec 31, 2024.

Clinical Overview

Use

Bovine colostrum may have a role in the management of HIV-associated diarrhea. There is increasing evidence of efficacy in boosting the immune system, preventing upper respiratory tract infection, reducing GI permeability, and enhancing athletic performance, although data are conflicting and are based on small sample sizes and studies of limited quality.

Dosing

Standardization of commercial bovine colostrum products is difficult because antibody content varies widely. Dosages up to 60 g/day for up to 12 weeks have been used in clinical trials evaluating use for athletic enhancement. In trials using bovine colostrum for exercise-induced GI permeability, dosages of 20 g/day for 14 days, or 1 g/day for 20 days have been used; in one trial, a dosage of 1.7 g/kg/day for 7 days prior to an exercise protocol was used.

Contraindications

Contraindications other than milk allergy have not been identified.

Pregnancy/Lactation

Avoid use. Information regarding safety and efficacy in pregnancy and lactation is lacking.

Interactions

None well documented.

Adverse Reactions

Bovine colostrum is well tolerated, with minor GI complaints (eg, nausea, flatulence, diarrhea), unpleasant taste, and skin rash occurring infrequently.

Toxicology

The US Food and Drug Administration (FDA) has accepted the safety of hyperimmune milks on the basis that no adverse health effects have been shown in clinical studies. Past concerns regarding transmission of bovine spongiform encephalopathy (BSE), a feed-borne infection in cattle, have been resolved.

Source

Bovine colostrum is the premilk fluid produced from mammary glands of a cow during the first 2 to 4 days after giving birth. It is a rich natural source of nutrients, antibodies, immunoglobulins, antimicrobial peptides, and growth factors for the newborn calf. Bovine colostrum is collected from dairy cows shortly after calving.Hurley 2011, Rathe 2014

History

The use of colostrum for both medicinal and spiritual purposes has been documented in traditional Ayurvedic medicine and among the ancient Hindu rishis (spiritual leaders) of India. At the turn of the 20th century, the use of colostrum was advocated to protect infants against both human and bovine infections. Prior to the advent of sulfa drugs and other antibiotics, colostrum was used to boost defense against immune diseases. Albert Sabin isolated antipolio antibodies in bovine colostrum in the 1950s; the first experiments with hyperimmune colostrum were conducted in the 1960s. Human lactoferrin is now produced via recombinant techniques and has been studied in preterm infants and neonates for the prevention and treatment of necrotizing enterocolitis.Struff 2007

Chemistry

Colostrum contains immunoglobulins (immunoglobulin G [IgG], IgA, and IgM), polypeptides and glycoproteins, lactoferrin, cytokines (including interleukins, interferon-gamma, and tumor necrosis factor alpha), lactoperoxidase, lysozyme, growth factors (including insulinlike, vascular endothelial, platelet-derived, and fibroblast growth factors), caseins, bioactive oligosaccharides, vitamins, fats, and minerals. Additionally, microRNA that may have immune-regulating activity is present in microvesicles.

Concentrations of immunoglobulins, which are dependent on the animal species, decline sharply in the first few days postpartum. Unlike humans, bovine maternal immunoglobulins do not cross the placenta and are retained in large quantities in the colostrum. In humans, the IgG component is transferred via the placenta before birth, whereas in bovine colostrum, it is the major immunoglobulin present (30 to 200 mg/mL vs 0.4 mg/mL in human colostrum). Immunoglobulins protect the gut mucosa from microbial invasion and offer passive immunity to the neonate until its own immune system is functioning optimally. IgG activates complement bacterial opsonization and agglutination and binds specifically to bacteria or their products. Hyperimmune bovine colostrum is produced by immunizing cows against specific microorganisms; studies using hyperimmune colostrum versus colostrum from nonimmunized cows should be interpreted cautiously.

Often, commercial producers attempt to differentiate their products on the basis of IgG content or by specifying the collection time for the colostrum; however, no specific standards exist. Processing of colostrum can lead to loss in IgG potency. Ultra–high temperature pasteurization (95°C [203°F]) destroys the majority of the immunoglobulin content; however, typical pasteurization (40°C [104°F]) results in less loss. The addition of stabilizers (sugars, glycerol) can further protect the IgG from thermal conformational changes. Many constituents of bovine colostrum, such as insulinlike growth factors, are resistant to dairy processing. However, compounds like cytokines are more labile. Techniques for analysis include gel and capillary electrophoresis and immunoassay techniques, including enzyme-linked immunosorbent assay.Gapper 2007, Hurley 2011, Korhonen 2007, Rathe 2014, Struff 2007

Uses and Pharmacology

Note: The lack of standardization of products reduces the external validity of clinical trial data; results indicating efficacy of a particular colostrum product cannot be generalized to apply to other products.

The relative safety of bovine colostrum, together with the lack of standardization of commercial products, makes animal studies largely irrelevant.

Athletic performance enhancement

Clinical data

The potential use of bovine colostrum for athletic enhancement is related to its growth factor content. Bovine IGF-I is structurally identical to human proteins, and short-term studies have been conducted in both high-performance (elite) athletes and other athletes by a limited pool of researchers.(Kelly 2003, Shing 2013) Findings from these studies are inconsistent, with some, but not all, showing enhanced performance and changes in body composition. The studies are small, and it may be that a change in performance is more difficult to detect in elite athletes.(Kelly 2003) Equivocal results regarding effects of bovine colostrum supplementation on immune function and intestinal permeability in athletes have also been demonstrated.(Buckley 2009, Carol 2011, Crooks 2010, Marchbank 2011, Shing 2006) Equivocal results were reported in a systematic review of clinical use of oral bovine supplementation; a total of 14 studies related to athletic performance were identified (N=370 elite and recreational athletes, with study sizes ranging from 9 to 49 participants). Dosages ranged from 10 to 60 g/day for 2 to 12 weeks; the most commonly used dosage was 60 g/day for 4 to 9 weeks. Quality of the studies was considered adequate; however, extrapolating a consensus was difficult because end points were heterogeneous.(Rathe 2014) In a double-blind, randomized, controlled study (N=40), use of bovine colostrum protein concentrate in elite male cyclists was associated with a significant increase in morning cortisol (P=0.004) and maintenance of testosterone (P≤0.05) compared with control (whey protein concentrate) throughout the duration of a 5-day stage race. The dose used in this small pilot study (N=10) was 10 g/day taken for 8 weeks prior to the race as well as during the 5-day race.(Shing 2013) In adults older than 50 years performing resistance training, supplementation with 20 g of bovine colostrum 3 times daily for 8 weeks significantly improved muscle strength (P=0.026), leg press strength (P=0.045), and bone turnover (P=0.024) compared with those taking whey protein. Participants in both groups experienced improvements in cognitive function, lean tissue mass, and upper body strength. GI-related adverse events occurred in 5 patients. Two patients in the colostrum group experienced mild bloating, nausea, diarrhea, and unsettled stomach that were classified as "possibly" or "probably" related to bovine colostrum and led to 1 dose reduction. In the whey group, 2 patients experienced moderate gastroesophageal reflux that was classified as "definitely" related to whey protein and led to discontinuation of the supplement; 1 participant experienced mild nausea considered "possibly" related to whey.(Duff 2014)

GI effects

Clinical data

Limited small studies have evaluated the efficacy of bovine colostrum in immunodeficiency-related diarrhea (cryptosporidiosis). The studies are generally limited methodologically,(Abubakar 2007, Florén 2006, Okhuysen 1998, Plettenberg 1993, Rump 1992) but at least 1 single-blind randomized trial has been conducted.(Kaducu 2011) Reductions in stool frequency, weight loss, and self-reported fatigue, as well as increases in CD4+ count have been reported.(Florén 2006, Kaducu 2011) A systematic review identified 5 studies (N=182, with study sizes ranging from 3 to 87 participants) that published data on the effects of bovine colostrum in patients with HIV-associated diarrhea and associated loss of gut mucosal CD4+ cells. Doses for most studies ranged from 10 to 32 g/day given for 10 days to 4 weeks. Collectively, the studies supported effectiveness of bovine colostrum, likely due to mechanisms involving direct antimicrobial effects, neutralization of endotoxins, suppression of gut inflammation, promotion of mucosal integrity, and tissue repair. However, the studies were of poor quality.(Rathe 2014)

Studies evaluating treatment of diarrhea from other bacterial causes (including Escherichia coli, Shigella, and Clostridium difficile) have also shown efficacy of bovine colostrum,(Lissner 1996, Lissner 1998, Mattila 2008, Otto 2011, Tacket 1992) while no effect was observed in studies of patients infected with Vibrio cholerae.(Kelly 2003)

Immunoglobulin-enriched colostrum was reported to provide improved endotoxin-neutralizing capability against postsurgical translocation of microbes in patients undergoing intra-abdominal surgery, whereas no benefit was reported in coronary artery bypass patients who received a standard colostrum preparation.(Rathe 2014)

Efficacy against Helicobacter pylori and nonsteroidal anti-inflammatory drug (NSAID)–induced GI injury has been demonstrated in a few clinical studies; however, other studies have not produced positive results.(Bitzan 1998, Buckley 2009, Kelly 2003) A systematic review of studies evaluating standard bovine colostrum oral supplementation identified 51 studies (N=2,326, with study sizes ranging from 3 to 605 patients); only 2 studies were of high quality. Data from the only 2 studies (n=7 and n=15) evaluating use in NSAID-induced GI injury showed evidence of possible benefit and protection of gut permeability; however, the studies were small and of short duration.(Rathe 2014)

A small, double-blind, randomized, placebo-controlled, 2-arm crossover trial investigated the effect of bovine colostrum and control (corn flour) on performance outcomes, GI permeability, and inflammatory markers during exercise in the heat in trained (n=7) as well as untrained (n=8) participants. The dose of bovine colostrum was 1.7 g/kg/day for 7 days prior to the exercise protocol. One performance measure (respiratory exchange ratio) and one measure of thermal strain were significantly improved in the colostrum group compared with controls (P<0.05 and P=0.004, respectively). No significant differences were found between groups for other measures, including cardiovascular strain, GI permeability, inflammatory cytokine response, and GI distress. No adverse effects or illnesses were reported.(Morrison 2014) However, 2 small, double-blind, randomized, placebo-controlled crossover studies (N=18 and N=16) found that bovine colostrum dosed at either 20 g/day for 14 days or 1 g/day for 20 days blunted exercise-induced GI permeability in healthy young males who exercised regularly.(Halasa 2017, March 2017)

Intestinal permeability in critically ill adults improved significantly in patients who received early enteral bovine colostrum supplementation (within 48 hours of ICU admission) compared to placebo in a double-blind, randomized, controlled study (N=70). The results were based on day 10 plasma zonulin (P<0.001) and endotoxin levels (P=0.007). Bovine colostrum was administered at 20 g/day for 10 days. The incidence of diarrhea was significantly lower in the colostrum group than controls (9% vs 33%; P=0.021).(Eslamian 2019)

In children with newly diagnosed acute lymphoblastic leukemia (ALL) who were starting the 29-day induction therapy based on the Nordic Society of Pediatric Hematology and Oncology ALL 2008 protocol, adjunctive supplementation with bovine colostrum significantly reduced the peak severity of chemotherapy-induced oral mucositis (P=0.02) compared to placebo in this double-blind, randomized trial but did not impact overall occurrence or severity. Additionally, no difference was found between groups in chemotherapy-induced intestinal mucositis or peak severity of abdominal pain or diarrhea. According to questionnaire scores, an improvement was reported in oral mucositis in the colostrum group compared to placebo only during week 1 (odds ratio, 0.19; 95% confidence interval, 0.04 to 0.88; P=0.03). The incidence of fever, inflammation (eg, plasma C-reactive protein levels), and infection as well as the proportion of patients given IV antibiotics was similar between treatment groups.(Rathe 2020)

Clinical evidence does not support results demonstrated in animal studies for beneficial effects in short bowel syndrome. Additionally, limited data have shown no benefit in patients with irritable bowel syndrome.(Rathe 2014)

Immunomodulatory activity

Animal data

Various concentrations of bovine colostral constituents, including certain immunoglobulins, have been studied in calves fed colostrum or colostral supplement products.(Garry 1996, Hopkins 1997, Mee 1996, Morin 1997, Quigley 1998)

Clinical data

Due to its immune factor constituents (immunoglobulins, cytokines, lactoferrin, and lactoperoxidase), bovine colostrum is considered an immune system supplement.(Kelly 2003, Shing 2007) However, clinical studies are sparse and diverse in the methodologies employed, products and dosages used, and in the conditions being evaluated.

Equivocal results have been reported regarding immune enhancement among athletes.(Carol 2011, Crooks 2010, Jones 2017, Shing 2007) Both a lack of effect on CD4+ counts(Byakwaga 2011) and a positive effect have been reported. In one small study, exercise-induced immune dysfunction improved with bovine colostrum compared with placebo in healthy, recreationally active men. Concentrations of insulinlike growth factor 1 (IGF-1), which may influence antidoping tests, were not affected.(Jones 2017)

A systematic review of 10 studies found some support for the use of bovine colostrum for preventing upper respiratory tract infection (URTI); however, caution is warranted in interpreting the results because statistical significance was only found in pooled self-reported data. Additionally, heterogeneity was found in study populations, dosages, formulations, quality of methodologies, and results. The evidence did not support benefit for the increased susceptibility to URTI that results from exercise-induced immunosuppression.(Kaducu 2011, Rathe 2014) In contrast, data from a double-blind, randomized, controlled trial (N=57) showed a significantly reduced proportion of days and episodes of URTI in male endurance athletes who consumed bovine colostrum (20 g/day) compared with controls. Also during the 12-week trial, a significantly lower proportion of athletes reported URTI in the colostrum group compared with placebo (12% vs 36%, respectively) at 5 to 8 weeks (P=0.044) but not at 1 to 4 weeks or 9 to 12 weeks.(Jones 2014) The effect of colostrum on key mucosal immune parameters (ie, the salivary antimicrobial peptide lactoferrin, salivary IgA) and neutrophil cytotoxic activity in response to exercise was investigated in a double-blind, randomized, placebo-controlled trial in 20 healthy males. Bovine colostrum supplementation (10 g twice daily for 4 weeks) significantly improved neutrophil functional activity compared with controls (P<0.05) but not any of the other parameters tested.(Jones 2015)

Other uses

Bovine colostrum has been studied in oral hygiene products, as a tear substitute, as an enema in distal colitis, and in very limited clinical studies in type 2 diabetes, juvenile idiopathic arthritis, multiple sclerosis, and chronic pain syndrome, and for presurgical use.(Hurley 2011, Kelly 2003, Kim 2009, Langmead 2006, Rathe 2014)

Dosing

Standardization of commercial bovine colostrum products is difficult because antibody content varies widely, making comparisons difficult. Additionally, hyperimmune preparations are available that are collected from cows previously immunized with specific organisms and that contain large amounts of specific antibodies.Kelly 2003 Studies have used the following dosages:

Athletic performance enhancement

10 to 60 g/day for up to 12 weeks.Buckley 2009, Carol 2011, Crooks 2010, Rathe 2014, Shing 2007

Exercise-induced GI permeability

Dosages of 20 g/day of bovine colostrum for 14 days,March 2017, Marchbank 2011 or 1 g/day for 20 days have been usedHalasa 2017; in one trial, 1.7 g/kg/day for 7 days prior to an exercise protocol was used.Morrison 2014

Immune deficiency–related diarrhea

10 to 50 g/day for 10 days to 4 weeks.Florén 2006, Kaducu 2011, Rathe 2014

Infectious disease

10 g/day as a supplement has been evaluated as treatment and prophylaxis.Kelly 2003, Shing 2007

Intra-abdominal surgery

56 g 3 days prior to surgery for prevention of postsurgical microbial translocation.Rathe 2014

NSAID–associated GI effects

Two small trials used 125 mL 3 times daily for 7 days.Rathe 2014

Prevention of upper respiratory tract infection

10 g twice daily for 4 or 12 weeks has been used in athletes.Jones 2014, Jones 2015

Pregnancy / Lactation

Avoid use. Information regarding safety and efficacy in pregnancy and lactation is lacking.

Interactions

None well documented.

Adverse Reactions

In most clinical trials, bovine colostrum has been well tolerated, with only infrequent reports of minor GI complaints (eg, nausea, flatulence, diarrhea), unpleasant taste, and skin rash.Kelly 2003, Rathe 2014 Intolerance to lactose and sensitivity to milk proteins most likely contributed to these effects.Struff 2008

Toxicology

The FDA has accepted the safety of hyperimmune milks on the basis that no adverse health effects have been shown in clinical studies.Gapper 2007

Previously specific commercial colostrum products were theoretically associated with a risk of BSE; therefore, lactobin LC1 was withdrawn from the market in the 1990s. Newer versions (LC2N) are derived from animals in countries with strict veterinary controls and without incidence of BSE, and where pasteurization is conducted at 72°C (167°F) for 15 seconds. The BSE risk for milk and milk products was determined to be negligible by the Committee for Proprietary Medicinal Products of the European Commission and by the World Health Organization, provided the milk is obtained from healthy animals and is prepared under suitable conditions.Struff 2007, Vetrugno 2004

References

Disclaimer

This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.

This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.

Abubakar I, Aliyu SH, Arumugam C, Hunter PR, Usman NK. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database Syst Rev. 2007;(1):CD004932.17253532
Bitzan MM, Gold BD, Philpott DJ, et al. Inhibition of Helicobacter pylori and Helicobacter mustelae binding to lipid receptors by bovine colostrum. J Infect Dis. 1998;177(4):955-961.9534968
Buckley JD, Butler RN, Southcott E, Brinkworth GD. Bovine colostrum supplementation during running training increases intestinal permeability. Nutrients. 2009;1(2):224-234.22253980
Byakwaga H, Kelly M, Purcell DF, et al; CORAL Study Group. Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4+ T-cell response: a randomized controlled trial. J Infect Dis. 2011;204(10):1532-1540.21930607
Carol A, Witkamp RF, Wichers HJ, Mensink M. Bovine colostrum supplementation's lack of effect on immune variables during short-term intense exercise in well-trained athletes. Int J Sport Nutr Exerc Metab. 2011;21(2):135-145.21558575
Crooks C, Cross ML, Wall C, Ali A. Effect of bovine colostrum supplementation on respiratory tract mucosal defenses in swimmers. Int J Sport Nutr Exerc Metab. 2010;20(3):224-235.20601740
Duff WR, Chilibeck PD, Rooke JJ, Kaviani M, Krentz JR, Haines DM. The effect of bovine colostrum supplementation in older adults during resistance training. Int J Sport Nutr Exerc Metab. 2014;24(3):276-285.24281841
Eslamian G, Ardehali SH, Baghestani AR, Vahdat Shariatpanahi Z. Effects of early enteral bovine colostrum supplementation on intestinal permeability in critically ill patients: A randomized, double-blind, placebo-controlled study. Nutrition. 2019;60:106-111. doi:10.1016/j.nut.2018.10.01330551120
Florén CH, Chinenye S, Elfstrand L, Hagman C, Ihse I. ColoPlus, a new product based on bovine colostrum, alleviates HIV-associated diarrhoea. Scand J Gastroenterol. 2006;41(6):682-686.16716966
Gapper LW, Copestake DE, Otter DE, Indyk HE. Analysis of bovine immunoglobulin G in milk, colostrum and dietary supplements: a review. Anal Bioanal Chem. 2007;389(1):93-109.17579844
Garry FB, Adams R, Cattell MB, Dinsmore RP. Comparison of passive immunoglobulin transfer to dairy calves fed colostrum or commercially available colostral-supplement products. J Am Vet Med Assoc. 1996;208(1):107-110.8682697
Hałasa M, Maciejewska D, Baśkiewicz-Hałasa M, Machaliński B, Safranow K, Stachowska E. Oral supplementation with bovine colostrum decreases intestinal permeability and stool concentrations of zonulin in athletes. Nutrients. 2017;9(4). Pii: E370.28397754
Hopkins BA, Quigley JD 3rd. Effects of method of colostrum feeding and colostrum supplementation on concentrations of immunoglobulin G in the serum of neonatal calves. J Dairy Sci. 1997;80(5):979-983.9178139
Hurley WL, Theil PK. Perspectives on immunoglobulins in colostrum and milk. Nutrients. 2011;3(4):442-474.22254105
Jones AW, Cameron SJ, Thatcher R, Beecroft MS, Mur LA, Davison G. Effects of bovine colostrum supplementation on upper respiratory illness in active males. Brain Behav Immun. 2014;39:194-203.24200515
Jones AW, Thatcher R, March DS, Davison G. Influence of 4 weeks of bovine colostrum supplementation on neutrophil and mucosal immune responses to prolonged cycling. Scand J Med Sci Sports. 2015;25(6):788-796.25727914
Jones AW, March DS, Thatcher R, Diment B, Walsh NP, Davison G. The effects of bovine colostrum supplementation on in vivo immunity following prolonged exercise: a randomised controlled trial [published online ahead of print December 22, 2017]. Eur J Nutr. 2017.2927403410.1007/s00394-017-1597-6
Kaducu FO, Okia SA, Upenytho G, Elfstrand L, Florén CH. Effect of bovine colostrum-based food supplement in the treatment of HIV-associated diarrhea in Northern Uganda: a randomized controlled trial. Indian J Gastroenterol. 2011;30(6):270-276.22161540
Kelly GS. Bovine colostrums: a review of clinical uses [published correction appears in Altern Med Rev. 2004;9(1):69]. Altern Med Rev. 2003; 8(4):378-394.14653766
Kim JH, Jung WS, Choi NJ, Kim DO, Shin DH, Kim YJ. Health-promoting effects of bovine colostrum in type 2 diabetic patients can reduce blood glucose, cholesterol, triglyceride and ketones. J Nutr Biochem. 2009;20(4):298-303.18602824
Korhonen H, Pihlanto A. Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr Pharm Des. 2007;13(8):829-843.17430184
Langmead L, Rampton DS. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther. 2006;23(3):341-349.16422993
Lissner R, Schmidit H, Karch H. A standard immunoglobulin preparation produced from bovine colostra shows antibody reactivity and neutralization activity against Shiga–like toxins and EHEC-hemolysin of Escherichia coli O157:H7. Infection. 1996;24(5):378-383.8923050
Lissner R, Thürmann PA, Merz G, Karch H. Antibody reactivity and fecal recovery of bovine immunoglobulins following oral administration of a colostrum concentrate from cows (Lactobin) to healthy volunteers. Int J Clin Pharmacol Ther. 1998;36(5):239-245.9629986
March DS, Marchbank T, Playford RJ, Jones AW, Thatcher R, Davison G. Intestinal fatty acid-binding protein and gut permeability responses to exercise. Eur J Appl Physiol. 2017;117(5):931-941.28290057
Marchbank T, Davison G, Oakes JR, et al. The nutriceutical bovine colostrum truncates the increase in gut permeability caused by heavy exercise in athletes. Am J Physiol Gastrointest Liver Physiol. 2011;300(3):G477-G484.21148400
Mattila E, Anttila VJ, Broas M, et al. A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial. Scand J Infect Dis. 2008;40(9):702-708.19086244
Mee JF, O'Farrell KJ, Reitsma P, Mehra R. Effect of a whey protein concentrate used as a colostrum substitute or supplement on calf immunity, weight gain, and health. J Dairy Sci. 1996;79(5):886-894.8792287
Morin DE, McCoy GC, Hurley WL. Effects of quality, quantity, and timing of colostrum feeding and addition of a dried colostrum supplement on immunoglobulin G1 absorption in Holstein bull calves. J Dairy Sci. 1997;80(4):747-753.9149969
Morrison SA, Cheung SS, Cotter JD. Bovine colostrum, training status, and gastrointestinal permeability during exercise in the heat: a placebo-controlled double-blind study. Appl Physiol Nutr Metab. 2014;39(9):1070-1082.25068884
Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET, DuPont HL. Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis. 1998;26(6):1324-1329.9636857
Otto W, Najnigier B, Stelmasiak T, Robins-Browne RM. Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers. Scand J Gastroenterol. 2011;46(7-8):862-868.21526980
Plettenberg A, Stoehr A, Stellbrink HJ, Albrecht H, Meigel W. A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea. Clin Investig. 1993;71(1):42-45.8453259
Quigley JD 3rd, Fike DL, Egerton MN, Drewry JJ, Arthington JD. Effects of a colostrum replacement product derived from serum on immunoglobulin G absorption by calves. J Dairy Sci. 1998;81(7):1936-1939.9710762
Ramesh Menon P, Lodha R, Kabra SK. Bovine colostrum in pediatric respiratory diseases: a systematic review. Indian J Pediatr. 2010;77(1):108-109.19936658
Rathe M, De Pietri S, Wehner PS, et al. Bovine colostrum against chemotherapy-induced gastrointestinal toxicity in children with acute lymphoblastic leukemia: A randomized, double-blind, placebo-controlled trial. JPEN J Parenter Enteral Nutr. 2020;44(2):337-347. doi:10.1002/jpen.152830861163
Rathe M, Müller K, Sangild PT, Husby S. Clinical applications of bovine colostrum therapy: a systematic review. Nutr Rev. 2014;72(4):237-254.24571383
Rump JA, Arndt R, Arnold A, et al. Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Clin Investig. 1992;70(7):588-594.1392428
Shing CM, Jenkins DG, Stevenson L, Coombes JS. The influence of bovine colostrum supplementation on exercise performance in highly trained cyclists. Br J Sports Med. 2006;40(9):797-801.16825268
Shing CM, Peake J, Suzuki K, et al. Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. J Appl Physiol (1985). 2007;102(3):1113-1122.17095643
Shing CM, Peake JM, Suzuki K, Jenkins DG, Coombes JS. A pilot study: bovine colostrum supplementation and hormonal and autonomic responses to competitive cycling. J Sports Med Phys Fitness. 2013;53(5):490-501.23903529
Struff WG, Sprotte G. Bovine colostrum as a biologic in clinical medicine: a review. Part I: biotechnological standards, pharmacodynamic and pharmacokinetic characteristics and principles of treatment. Int J Clin Pharmacol Ther. 2007;45(4):193-202.17474538
Struff WG, Sprotte G. Bovine colostrum as a biologic in clinical medicine: a review—Part II: clinical studies. Int J Clin Pharmacol Ther. 2008;46(5):211-225.18538107
Tacket CO, Binion SB, Bostwick E, Losonsky G, Roy MJ, Edelman R. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am J Trop Med Hyg. 1992;47(3):276-283.1524140
Vetrugno V. Safety of milk and milk derivatives in relation to BSE: the lactoferrin example. Biometals. 2004;17(3):353-356.15222490

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Copyright © 2025 Wolters Kluwer Health